AASLD 2012

Name: AASLD 2012
Location: Boston, USA

'The Liver Meeting 2012', the 63rd annual meeting of the American Association for the Study of Liver Diseases (AASLD), took place in Boston, USA, 9-13th November 2012.

9-13 November 2012
Boston, USA

New & experimental hepatitis C treatment

12 November 2012

Read the article

Mark Sulkowski from Johns Hopkins University School of Medicine. © Liz Highleyman / hivandhepatitis.com

New & experimental hepatitis C treatment

12 November 2012

Read the article

Hepatitis C symptoms & diagnosis

11 November 2012

Read the article

Previous
Page 2 of 2
1
2

Get regular email bulletins

Your first name *

Your last name *

Your email address *

Please let us know how you'd like to be contacted by ticking the options below.

Yes, I’d like to receive aidsmap email bulletins to keep up to date with the latest research, news and developments in HIV

Yes, I’d like to receive regular newsletter emails about what Terrence Higgins does

AASLD 2012

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

Receive the latest HIV research and conference news

Get regular email bulletins

AASLD 2012

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

Receive the latest HIV research and conference news

Get regular email bulletins

Get regular email bulletins